Anal carcinoma--a histological review

Area of Science:

• Oncology
• Virology
• Epidemiology

Background:

• Anal carcinoma is associated with Human Immunodeficiency Virus (HIV) and Human Papillomavirus (HPV).
• Oncogenic HPV types, particularly HPV 16/18, are implicated in anal cancer development.
• HIV-positive individuals and those with anal warts show increased anal dysplasia risk.

Purpose of the Study:

• To investigate the association between anal carcinoma, HIV, and HPV.
• To understand the pathogenesis and classification of anal carcinomas.
• To review current management strategies and future research directions.

Main Methods:

• Review of epidemiological and experimental evidence.
• Analysis of HPV DNA in tumor samples.
• Examination of clinical studies on anal dysplasia and patient outcomes.

Main Results:

• Over 85% of anal tumors contain HPV 16/18 DNA.
• Anal dysplasia is common in HIV-positive patients and those with anal warts.
• Squamous cell carcinoma is the predominant type, with ductal differentiation and mucin production indicating a worse prognosis.

Conclusions:

• Anal carcinoma pathogenesis involves HPV, with potential synergistic effects with HIV.
• Accurate classification and staging are crucial for patient management.
• Chemoradiotherapy is replacing surgery as the primary treatment, reducing morbidity.